Tetracaine
- Generic Name
- Tetracaine
- Brand Names
- Ametop, Cetacaine, Kovanaze, One Touch Reformulated Apr 2009, Pliaglis, Synera, Zap
- Drug Type
- Small Molecule
- Chemical Formula
- C15H24N2O2
- CAS Number
- 94-24-6
- Unique Ingredient Identifier
- 0619F35CGV
- Background
Tetracaine is an ester local anaesthetic currently available in combination with lidocaine as a cream and patch.
- Indication
Ophthalmic tetracaine is indicated for the for procedures requiring a rapid and short- acting topical ophthalmic anesthetic.
The combination lidocaine and tetracaine patch is indicated for local dermal analgesia for superficial dermatological procedures and superficial venous access. The combination lidocaine and tetracaine cream is intended to provide topical local analgesia for superficial dermatological procedures.
- Associated Conditions
- Dermabrasion, Haemorrhoids, Insect Bites, Rash caused by poison ivy, Sunburn, Minor burns
- Associated Therapies
- Local Anaesthesia therapy, Local Anesthesia of the Skin
Efficacy and Safety of Synera in Osteoarthritis Pain
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Thomas J. Schnitzer
- Target Recruit Count
- 40
- Registration Number
- NCT01654302
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Pharmacokinetic Study of Synera in Healthy Volunteers
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2012-10-17
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01602757
- Locations
- 🇺🇸
Cetero Research, Fargo, North Dakota, United States
Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome
- Conditions
- Shoulder Pain
- Interventions
- First Posted Date
- 2012-03-05
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Injury Care Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01544283
- Locations
- 🇺🇸
Injury Care Medical Center, Boise, Idaho, United States
Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow
- Conditions
- Epicondylitis of the Elbow
- Interventions
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- International Clinical Research Institute
- Target Recruit Count
- 78
- Registration Number
- NCT01525043
- Locations
- 🇺🇸
International Clinical Research Institute, Overland Park, Kansas, United States
Tetracaine Versus Lidocaine Gel for Anesthetic Effect and Comfort in Patients Undergoing LASIK
- First Posted Date
- 2011-06-28
- Last Posted Date
- 2017-08-11
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 11
- Registration Number
- NCT01383200
- Locations
- 🇺🇸
Bascom Palmer Eye Institute, Miami, Florida, United States
Dose-Escalation Safety and Pharmacokinetic Study of K305
- Conditions
- Anesthesia
- Interventions
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- St. Renatus, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT01304316
- Locations
- 🇺🇸
University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania, United States
Intravitreal Injection Anesthesia - Comparison of Different Topical Agents
- Conditions
- Age-Related Macular Degeneration (AMD)
- Interventions
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2012-04-19
- Lead Sponsor
- Lawson Health Research Institute
- Target Recruit Count
- 92
- Registration Number
- NCT01224847
- Locations
- 🇨🇦
Ivey Eye Institute, London, Ontario, Canada
Comparison of Synera Patch Versus LMX-4 Cream Versus Placebo Patch for Pain Reduction During Venipuncture in Children
- Conditions
- VenipuncturePainAnesthetics, Local
- Interventions
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Carol Morreale
- Target Recruit Count
- 150
- Registration Number
- NCT01115062
- Locations
- 🇺🇸
Women and Children Hospital, Charleston, West Virginia, United States
Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2017-11-08
- Lead Sponsor
- Wake Forest University
- Target Recruit Count
- 46
- Registration Number
- NCT01005459
- Locations
- 🇺🇸
Forsyth Medical Center- OB Anesthesia dept, Winston-Salem, North Carolina, United States
Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome
- Conditions
- Carpal Tunnel Syndrome
- Interventions
- First Posted Date
- 2009-10-07
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- ZARS Pharma Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00991068
- Locations
- 🇺🇸
International Clinical Research Institute, Overland Park, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.